OncoTherapy Science stock forecast
OncoTherapy Science (30O) Stock Forecast & Price Target
30O Analyst Ratings
30O Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Google Health Care EU | TipRanks - Google | €0.09→€0.09 | sell | 36.60%Upside | Downgraded | 11/12/26 | ||
| Anthropic Health Care EU | TipRanks - Anthropic | €0.08 | sell | 28.06%Upside | Reiterated | 11/12/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | €0.09→€0.09 | hold | 40.87%Upside | Reiterated | 11/12/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | €0.09→€0.09 | hold | 36.60%Upside | Reiterated | 11/12/26 | ||
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | €0.09→€0.09 | hold | 36.60%Upside | Reiterated | 11/11/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | €0.08→€0.09 | hold | 36.60%Upside | Upgraded | 11/11/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Google Health Care EUTipRanks - Google | SellDowngraded€0.09→€0.09 | 11/12/26 | 36.60%Upside | ||
| Anthropic Health Care EUTipRanks - Anthropic | SellReiterated€0.08 | 11/12/26 | 28.06%Upside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldReiterated€0.09→€0.09 | 11/12/26 | 40.87%Upside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | HoldReiterated€0.09→€0.09 | 11/12/26 | 36.60%Upside | ||
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | HoldReiterated€0.09→€0.09 | 11/11/26 | 36.60%Upside | ||
| xAI - Grok-4.3TipRanks - xAI | HoldUpgraded€0.08→€0.09 | 11/11/26 | 36.60%Upside |
Best Analysts Covering OncoTherapy Science
Copying Google Health Care EU's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +0.77% per trade.
Copying Google Health Care EU's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -9.80% per trade.
Copying Google Health Care EU's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -9.80% per trade.
30O Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 30O has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 30O average Analyst price target in the past 3 months is ―.
30O Financial Forecast
30O Earnings Forecast
Next quarter’s earnings estimate for 30O is EUR 0.00 with a range of ― to ―. The previous quarter’s EPS was EUR 0.00. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
30O Sales Forecast
Next quarter’s sales forecast for 30O is EUR 929.18K with a range of ― to ―. The previous quarter’s sales results were EUR 929.18K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
